63
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

, , , , &
Pages 69-74 | Published online: 20 Jun 2016

References

  • TiongLMaddernGJSystematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinomaBr J Surg20119891210122421766289
  • CabreraRNelsonDRReview article: the management of hepatocellular carcinomaAliment Pharmacol Ther201031446147619925500
  • BruixJShermanMAmerican association for the study of liver DManagement of hepatocellular carcinoma: an updateHepatology20115331020102221374666
  • LoCMNganHTsoWKRandomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology20023551164117111981766
  • LlovetJMRealMIMontanaXArterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialLancet200235993191734173912049862
  • LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survivalHepatology200337242944212540794
  • LammerJMalagariKVoglTPRECISION V InvestigatorsProspective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V studyCardiovasc Intervent Radiol2010331415219908093
  • LewisALTaylorRRHallBGonzalezMVWillisSLStratfordPWPharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolizationJ Vasc Interv Radiol20061781335134316923981
  • LewisALGonzalezMVLeppardSWDoxorubicin eluting beads–1: effects of drug loading on bead characteristics and drug distributionJ Mater Sci Mater Med20071891691169917483878
  • HongKKhwajaALiapiETorbensonMSGeorgiadesCSGeschwindJFNew intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancerClin Cancer Res20061282563256716638866
  • GolfieriRGiampalmaERenzulliMPRECISION ITALIA STUDY GROUPRandomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinomaBr J Cancer2014111225526424937669
  • DhanasekaranRKoobyDAStaleyCAKauhJSKhannaVKimHSComparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)J Surg Oncol2010101647648020213741
  • SongMJChunHJSong doSComparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinomaJ Hepatol20125761244125022824821
  • HanishSIKnechtleSJLiver transplantation for the treatment of hepatocellular carcinomaOncology (Williston Park)201125875275721874838
  • VoglTJLammerJLencioniRLiver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trialAJR Am J Roentgenol20111974W562W57021940527
  • VarelaMRealMIBurrelMChemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokineticsJ Hepatol200746347448117239480
  • MalagariKAlexopoulouEChatzimichailKTranscatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC beadAbdom Imaging200833551251917938995
  • SongMJParkCHKimJDDrug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patientsEur J Gastroenterol Hepatol201123652152721537127
  • HuangKZhouQWangRChengDMaYDoxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinomaJ Gastroenterol Hepatol201429592092524224722
  • GaoSYangZZhengZDoxorubicin-eluting bead versus conventional TACE for unresectable hepatocellular carcinoma: a meta-analysisHepatogastroenterology20136012481382023282741
  • KloecknerRWeinmannAPrinzFConventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinomaBMC Cancer20151546526059447
  • FacciorussoAMarianiLSpositoCDrug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinomaJ Gastroenterol Hepatol201631364565326331807